TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
BWT Pharma & Biotech AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
63,990
|
43,709
|
29,864 |
| Financial expenses |
17
|
1
|
4 |
| Earnings before taxes |
13,577
|
7,018
|
4,335 |
| EBITDA |
13,226
|
6,870
|
4,366 |
| Total assets |
46,493
|
32,049
|
18,201 |
| Current assets |
46,318
|
31,912
|
18,066 |
| Current liabilities |
30,778
|
23,329
|
12,497 |
| Equity capital |
15,510
|
8,542
|
4,782 |
| - share capital |
44
|
45
|
45 |
| Employees (average) |
50
|
48
|
42 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
33.4%
|
26.7%
|
26.3% |
| Turnover per employee |
1,280
|
911
|
711 |
| Profit as a percentage of turnover |
21.2%
|
16.1%
|
14.5% |
| Return on assets (ROA) |
29.2%
|
21.9%
|
23.8% |
| Current ratio |
150.5%
|
136.8%
|
144.6% |
| Return on equity (ROE) |
87.5%
|
82.2%
|
90.7% |
| Change turnover |
21,767
|
13,757
|
11,615 |
| Change turnover % |
52%
|
46%
|
64% |
| Chg. No. of employees |
2
|
6
|
5 |
| Chg. No. of employees % |
4%
|
14%
|
14% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.